Serum C-reactive protein (CRP)/albumin ratio (CAR) is demonstrated as a more precise marker in determining the prognosis of critical diseases than albumin and CRP levels, separately. Recently, inflammatory biomarkers are increasingly used for both screening and prognosis of coronary artery disease (CAD). As an ischemia-dependent risk index, CAR is an independent marker of in-hospital and long-term all-cause mortality in ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention. The results indicate that CAR is a more effective prognostic marker than either CRP or albumin.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- coronary artery disease
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- coronary artery bypass grafting
- acute coronary syndrome
- cardiovascular events
- coronary artery bypass
- atrial fibrillation
- healthcare
- type diabetes
- oxidative stress
- aortic stenosis
- left ventricular
- acute care
- aortic valve